电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

VEGFR2/CD309 Protein (AA 807-1356) (His-GST)

This Recombinant VEGFR2/CD309 protein is expressed in Baculovirus infected Insect Cells.
产品编号 ABIN7317118
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for VEGFR2/CD309 Protein (AA 807-1356) (His-GST) (ABIN7317118)

抗原

See all VEGFR2/CD309 (VEGFR2) 蛋白
VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

蛋白类型

Recombinant

生物活性

Active

宿主

  • 36
  • 13
  • 4
  • 3
  • 1

资源

  • 28
  • 6
  • 6
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Baculovirus infected Insect Cells

纯度

> 78 % as determined by reducing SDS-PAGE.
  • 产品特性

    AA 807-1356

    标记

    This VEGFR2/CD309 protein is labelled with His-GST.

    原理

    Recombinant Human VEGFR2/Flk-1/KDR Protein (His &GST Tag)

    序列

    Asp807-Val1356

    产品特性

    A DNA sequence encoding the human KDR (NP_002244) (Asp807-Val1356) was fused with the N-terminal polyhistidine-tagged GST tag at the N-terminus.

    过滤

    0.2 μm filtered

    内毒素水平

    < 1.0 EU per μg of the protein as determined by the LAL method.

    Biological Activity Comment

    The specific activity was determined to be 10 nmol/min/mg using Poly(Glu, Tyr) 4:1 as substrate.
  • 想要此Protein的其他选项吗?

    !
    探索我们的预定义定制蛋白和定制蛋白服务!

    您的项目需要进一步定制吗?联系我们,了解我们的定制蛋白解决方案

  • 限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Supplied as sterile solution of 50 mM Tris, 100 mM NaCl, pH 8.0, 10 % glycerol, 2 mM GSH

    储存条件

    -20 °C

    储存方法

    Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.

    有效期

    6 months
  • 抗原

    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

    别名

    VEGFR2/Flk-1/KDR

    背景

    CD309,FLK-1,FLK1,Fetal liver kinase 1,Flk-1,KDR,Kinase insert domain receptor,Protein-tyrosine kinase receptor flk-1,VEGFR,VEGFR-2,VEGFR2,Vascular endothelial growth factor receptor 2,VEGFR2, also called as KDR or Flk-1, is identified as the receptor for VEGF and VEGFC and an early marker for endothelial cell progenitors, whose expression is restricted to endothelial cells in vivo. VEGFR2 was shown to be the primary signal transducer for angiogenesis and the development of pathological conditions such as cancer and diabetic retinopathy. It has been shown that VEGFR2 is expressed mainly in the endothelial cells, and the expression is upregulated in the tumor vasculature. Thus the inhibition of VEGFR2 activity and its downstream signaling are important targets for the treatment of diseases involving angiogenesis. VEGFR2 transduces the major signals for angiogenesis via its strong tyrosine kinase activity. However, unlike other representative tyrosine kinase receptors, VEGFR2 does not use the Ras pathway as a major downstream signaling but rather uses the phospholipase C-protein kinase C pathway to signal mitogen-activated protein (MAP)-kinase activation and DNA synthesis. VEGFR2 is a direct and major signal transducer for pathological angiogenesis, including cancer and diabetic retinopathy, in cooperation with many other signaling partners, thus, VEGFR2 and its downstream signaling appear to be critical targets for the suppression of these diseases. VEGF and VEGFR2-mediated survival signaling is critical to endothelial cell survival, maintenance of the vasculature and alveolar structure and regeneration of lung tissue. Reduced VEGF and VEGFR2 expression in emphysematous lungs has been linked to increased endothelial cell death and vascular regression.

    分子量

    Calculated MW: 89.3 kDa

    Observed MW: 110 kDa

    基因ID

    3791

    NCBI登录号

    NP_002244

    UniProt

    P35968

    途径

    RTK signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
You are here: